High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Discover key insights every first time investor should know. Equip yourself with the knowledge for a successful and rewarding investing experience.
28,352 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Investors are buzzing about QuantumScape after news of a major automaker collaboration. This article breaks down what...
A bold stake move in Hut 8 has sparked a new conversation about concentration, risk, and opportunity in crypto-relate...
Alphabet and Meta delivered divergent Q4 results, underscoring different paths to durable profits. Cloud, AI, and cap...
Ford and GM are reshaping their business models by moving into energy-related assets like batteries, charging network...
A large new stake underscores Core Scientific's shift toward data center services. This article breaks down the impli...
The Fundrise VCX fund, once a magnet for IPO-obsessed investors, dropped 45% from its peak as market enthusiasm for p...
When space stocks surge, investors want to know why. This article breaks down the drivers behind Planet Labs stock we...
In 2026, a wave of renewed focus on critical minerals has many investors watching USA Rare Earth. This guide explains...
Rocket Lab delivers a record quarter that lights up the stock market today. This deep dive explains the rally, the ba...
Meta Platforms has shown business momentum even as its stock traded lower. This guide weighs the case to buy, sell, o...
When a renowned activist investor signals a bold AI bet, markets take notice. Explore how billionaire Bill Ackman bet...